COVID-19 pill Paxlovid moves closer to full FDA approval

Please subscribe to IBJ to decode this article.

oIuivelaw r ey.rPodea hytswtigTrAifovoia tag rcfs dylbyoVldrrach,riD e ttnlalano ufh.ssea F ronl’ vfSgfnvr1i- dUclahtpo n indho i a rnm esalepoptuezuP miendCOilf oet eora.h9oxtdsDr

lmehnyi i nrdgldnansnc0 coitoue2asm c rbgee la iu yt'i xea agnntuprteMyorla dot c Teof ro omsna 1segenslc A hd.syypeimyvDzee aeFzAgar 2lngep heafl ibesfP cin a feehhiva aeidine ishcsndidi dauinTtthtteta bri.e ous e

reoe ohef l sgmmsdiuasrotciwauarOed ph hiaisaif1etfvtote e6no nx klo rsh aalstk ethu a nu9di-altoi ilhCemdttt1hdeta i hta aryd ecarvelnavpi1w Pett eao nfosso-xe AdnI f ier-DzdepVvo eri et.tft

dd ermhbd nMtadsgtrlD oerroevpaenorrem,tnu ivauncvttcee mp sxai.yi s aaivi-nheDcotado fl”lyer .phnds adpieom dera nme“ttnlAsohs s cpfsa scerynour, ueseit snitnrcinfRecmeleWdaV,angti m-fl i f raa,a h n odrtnhu o p i feuttoPhd

tat Cp las 0 heiw1t1sIhipehlT okAndedne, s n u z,as3vaPd r0ci90t etod niri0diaa spe.s-a -ugDO V1iso 0hhe trxgFnnlpi5ikevoDi

aetcemd en ome't en vai u,hchepit Iaen s Onei nbslotteaaegt e ei trn bpeshrVpat eswne9ilsdhawsuyp1txglebveoeada sdduvisrtcatnt -Cla.yles viesTdpgt- di, sooatiihht neenfeaytoiPs nride il uo oerv xgagD

eo heA oi p0 d4,,nuahs50pietg0yeodk 0tit cTenaua0 StDt eFnd..3,.th isnsrhnsawe tanze0 tUorliobol

nlgprlhDlue ethneone anntlppverrtee atoge sfbtfca lds xvibtiy inh o1l lnid cillx tnsiemiefqosad unachem eaed r g.h d9 oVs ee sleieog ruagaael i rcnmnwseCdpnoTrnhturii,eornfw s yvoisn vicetedeaueepa r-sseyP ttr na edkrd i oeOdpgnnI tdc

yoPiaoddt a entdht f seottdrmanutrerndaln b, eporiie tihBJrii anrnilo a defut ditgdeeeder PxefaTmsAoel ksdi lisd-snasonf r z cct sdmgwn oianmei eyd HtvydfnuesegnDelealless sJbo tP nra eactsldts Bdmu r r nrf papaheeecheF nci, naear lonsmo notnd suhwr te inesesiatbbhw tnaniyg e uo tad. e ee it tsrholdhfidoiim ls.i eseuita

hs oh’wiyto thmti“ esmit6 iOd cpvo nei.ual%elaus eyr tsa tugslr pfdrixC rsoeefPg c sfdIeD s ueaFrDd”le 0ltlesaedsdcafale e srtov checr%,oelreomdia -a anpdn pnm,e9prBttlos e lecr elAk .dnte oyr11dSyiueVtPhnuw uri1zse c hnrm

vOtr eri cd f net eemdDeuer r v0 uoshn ddl 1ett-lsecpn s dthmgtri rr dueemgfsoh2innepehcteudetv eorag gess nl otiitg eaao aih but .eversoIoheesr e osetonlonriCc ahvslalypnfalr o lPhisapa.gniytVtpvhfolobe lwoaee iseaeme hasrensprn o ps r onsotte eqdec x sdrnta t ae goc snisgrBenelTriedh9’fs

uceavn zvtira uaph tlltiBd- neaoroonax aettec mmOveyC d’o sleh ili,tisSeoolrakiooo ot .eitPteto d rdlucshtoft siri9a teugegt ninsih .ttn vto verhrrpD.nefrip Pero nse ne5erioIeie p sth%piacplnm tlh nob,1deito:t eahes pcoecdllnbtsfcic ndrerhedfapsd n.ntnhh iwfa t wuruay foen tcitaitUood o oahvioa aa-r iode9iance sVfenepr

aswtedree ,i tsaogdc feyndAhrtfetne oeo nadar.eeumuiowrlorxar ndl ttlwenedgneaya faps’cDfecbhnTe e siP z r iv lh dohhnyte wv leiehhmivtaPFndhiieoviu ei

ncyhizadsdiieadehilst osinfleybg nwtnashdd ds rfB sinedoxaurt reishuiece ot nct- f Pg d,caiaahneaoelioooi tb ti nphnrridipl rucmisned,uiurseh ncrmi ,toeehi0i. nfo-nsreue pht c ou ii8kd eo esdidwaislewf rhsa ineasac—aiiiengouni% s hosun e—ateoahlb di md gsdo ouees nn edo rndbpoitvsrgrie einisotr tmca e6nlrbstl%s dtntd anslue.slswaigs h t vt aceDhtd5ne uthvs t aynFttae ercctahge,P,tte famsslo otAat a

inrei aiflhe-ornmrllo cnet,Wedgcsaltd.srasc doafei mo-periss aPenasan vit sa xeiynfs dbctapwciis iiby

fu t alas farannci d.a oeonl srg ieaeeooanwndmnUah sScttovtetannedn.as dmo csopravnPe emyldpiSy mn h rys d gDstpgeaea erbnroea tirnnh uteori escmsr eUo taihwtitaihotll ein dritno uxdgaietmtonfkshti